HIPEC Trials and the US: A Review and Call to Action

被引：4
作者：
Pameijer, Colette R. [1 ]
机构：
[1] Penn State Coll Med, Surg, Hershey, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / 02期
关键词：
Colorectal cancer; Clinical trial; Peritoneum; HIPEC; Metastasis; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; COLORECTAL PERITONEAL METASTASES; CYTOREDUCTIVE SURGERY; SYSTEMIC CHEMOTHERAPY; RANDOMIZED-TRIAL; CANCER-PATIENTS; CARCINOMATOSIS; MORBIDITY; MORTALITY; MALIGNANCIES;
D O I：
10.1245/s10434-021-10769-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：866 / 872
页数：7
相关论文
共 35 条
[1]   A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin [J].
Cao, Christopher ;
Yan, Tristan D. ;
Black, Deborah ;
Morris, David L. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (08) :2152-2165
[2]   Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial [J].
Cashin, P. H. ;
Mahteme, H. ;
Spang, N. ;
Syk, I. ;
Frodin, J. E. ;
Torkzad, M. ;
Glimelius, B. ;
Graf, W. .
EUROPEAN JOURNAL OF CANCER, 2016, 53 :155-162
[3]   Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure [J].
de Jong, Loek A. W. ;
Elekonawo, Fortune M. K. ;
de Reuver, Philip R. ;
Bremers, Andre J. A. ;
de Wilt, Johannes H. W. ;
Jansman, Frank G. A. ;
ter Heine, Rob ;
van Erp, Nielka P. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (01) :47-58
[4]  
De Somer F, 2008, PERITON DIALYSIS INT, V28, P61
[5]   Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance [J].
Elias, D ;
Matsuhisa, T ;
Sideris, L ;
Liberale, G ;
Drouard-Troalen, L ;
Raynard, B ;
Pocard, M ;
Puizillou, JM ;
Billard, V ;
Bourget, P ;
Ducreux, M .
ANNALS OF ONCOLOGY, 2004, 15 (10) :1558-1565
[6]   Treatment of peritoneal carcinomatosis from colorectal cancer: Impact of complete cytoreductive surgery and difficulties in conducting randomized trials [J].
Elias, D ;
Delperro, JR ;
Sideris, L ;
Benhamou, E ;
Pocard, M ;
Baton, O ;
Giovannini, M ;
Lasser, P .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (05) :518-521
[7]   Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin [J].
Elias, Dominique ;
Lefevre, Jeremie H. ;
Chevalier, Julie ;
Brouquet, Antoine ;
Marchal, Frederic ;
Classe, Jean-Marc ;
Ferron, Gwenael ;
Guilloit, Jean-Marc ;
Meeus, Pierre ;
Goere, Diane ;
Bonastre, Julia .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) :681-685
[8]  
ESQUIVEL J, 1993, SURGERY, V113, P631
[9]   Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy [J].
Feldman, AL ;
Libutti, SK ;
Pingpank, JF ;
Bartlett, DL ;
Beresnev, TH ;
Mavroukakis, SM ;
Steinberg, SM ;
Liewehr, DJ ;
Kleiner, DE ;
Alexander, HR .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4560-4567
[10]   Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures [J].
Foster, Jason M. ;
Sleightholm, Richard ;
Patel, Asish ;
Shostrom, Valerie ;
Hall, Bradley ;
Neilsen, Beth ;
Bartlett, David ;
Smith, Lynette .
JAMA NETWORK OPEN, 2019, 2 (01)
1234